Editas Medicine EDIT reported its Q3 earnings results on Wednesday, November 2, 2022 at 06:30 AM.
Here's what investors need to know about the announcement.
Earnings
Editas Medicine beat estimated earnings by 5.81%, reporting an EPS of $-0.81 versus an estimate of $-0.86.
Revenue was down $6.16 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.04 which was followed by a 2.46% increase in the share price the next day.
Here's a look at Editas Medicine's past performance:
Quarter | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
---|---|---|---|---|
EPS Estimate | -0.82 | -0.79 | -0.72 | -0.82 |
EPS Actual | -0.78 | -0.74 | -0.61 | -0.57 |
Revenue Estimate | 4.29M | 3.85M | 4.29M | 4.78M |
Revenue Actual | 6.36M | 6.77M | 12.47M | 6.20M |
To track all earnings releases for Editas Medicine visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.